Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study of combining nivolumab immunotherapy with radiation therapy and androgen deprivation therapy for pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • nivolumab (nivolumab)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer, Prostate Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING